History of the studies of meningococcal infection and bacterial meningites (1661–1961)


DOI: https://dx.doi.org/10.18565/epidem.2019.9.1.100-6

Platonov A.E., Platonova O.V., Maleev V.V.

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia
The historical review considers the most important milestones in studies of meningococcal infection and bacterial meningitis in 1661–1961. The development of conceptions on the aetiology, epidemiology and clinical presentation of purulent meningitis, the progress of diagnostic methods and methods of therapy are shown from epoch to epoch. The main researchers and clinicians who have made a significant contribution to the struggle against meningococcal infection are briefly described.
Keywords: bacterial meningitis, meningococcal infection, history of medicine
Read entire article

Literature

  1. Willis T. London Practice of Physick or the Whole Practical Part of Physick Contained in the Works of Dr. Willis. London: Baffet and Crook, 1685.
  2. Tyler K.L. Chapter 28: a history of bacterial meningitis. Handb. Clin. Neurol. 2010; 95: 417–33.
  3. Vieusseux G. Memoire sur la maladie qui a regne a Geneve au printemps de 1805. Journal de Medecine Chirurgie et Pharmacie 1805; 11: 163–82.
  4. Matthey A. Recherches sur une maladie particuliere quia regne a Geneve en 1805. Journal de Medecine Chirurgie et Pharmacie 1806; 11: 243–53.
  5. North E. A Treatise on a Malignant Epidemic Commonly Called Spotted Fever. New York: T. & J. Swords, 1811.
  6. North E. Concerning the Epidemic of Spotted Fever in New England. Rev. Infect. Dis. 1980; (2): 811–6.
  7. Steiner W.R. Dr. Elisha North, of New London, Connecticut, the Founder of the First Eye Infirmary in the United States. Trans. Am. Ophthalmol. Soc. 1932; 30: 374–86.
  8. Danielson L., Mann E. The history of a singular and very mortal disease, which lately made its appearance in Medfield. Medical and Agricultural Register 1806; (1): 65–9.
  9. Classics in infectious disease: the first American account of cerebrospinal meningitis. Rev. Infect. Dis. 1983; (5): 969–72.
  10. Breccia M., Foa R. Intravenous arsenic trioxide and all-trans retinoic acid as front-line therapy for low-risk acute promyelocytic leukemia. Expert. Rev. Hematol. 2018; Dec 20. DOI: 10.1080/17474086.2019.1562332. [Epub ahead of print].
  11. Kostуukova N.N., Bekhalo V.A., Chernyshova T.F. [Meningococcal infection in Russia: the past and the near future]. Èpidemiologiâ i infekcionnye bolezni. Аktual’nye voprosy 2014; (2): 73–9. (In Russ.).
  12. Godinho V. Meningite cerebroespinhal epidemica. Revista Medica de Sao Paulo 1906; IX: 129–32.
  13. Kernig V.M. Uber ein wenig bemerktes Meningitis-Symptom. Berliner Klinishe Wochenschrift 1884; 21: 829–32.
  14. Brudzinski J. Un signe nouveau sur les membres inferieurs dans les meningites chez les enfants (signe de la nuque). Arch. Med. Enfants 1909; (12): 745–52.
  15. Weichselbaum A. Uber die Atiologie der akuten Meningitis cerebrospinalis. Fortschritte der Medicin 1887; (5): 573–83, 620–6.
  16. Sternberg G.M. A fatal form of septicemia in the rabbit produced by subcutaneous inoculation of human saliva. Natl. Board Health Bull. 1881; (2): 781–3.
  17. Quincke H.I. Die Lumbalpunction des Hydrocephalus. Berliner Klinishe Wochenschrift 1891; 28: 929–33, 965–8.
  18. Quincke H. Über Meningitis serosa. Samml. Klin.Vortrage 1893; 67: 655.
  19. Quincke H. Über Lumbalpunction. Berliner Klinishe Wochenschrift 1895; 32: 861, 889–91.
  20. Merritt H.H., Fremont-Smith F. The Cerebrospinal Fluid. Philadelphia: WB Saunders, 1937.
  21. Vengerov Yu.Ya., Platonov A.E. [West Nile Fever. In: Sergiev V.P., Ushchuk N.D., Vengerov Yu.Ya., Zavoykin V.D. (eds.) Tropical diseases: a guide for doctors]. Moscow: BINOM Publishing House, 2015; 328–38. (In Russ.)
  22. Tyler K.L., Pape J., Goody R.J., Corkill M., Kleinschmidt-DeMasters B.K. CSF findings in 250 patients with serologically confirmed West Nile virus meningitis and encephalitis. Neurology 2006; 66(3): 361–5.
  23. Neufeld F. Uber die Agglutination der Pneumokokken und uber die Theorien der Agglutination. Z. Hyg. Infektionskr. 1902; 40: 54–72.
  24. Neufeld F., Händel L. Weitere Untersuchungen über Pneumokokken Heilsera. III Mitteilung. Über Vorkommen und Bedeutung atypischer Varietäten des Pneumokokkus. Arbeit aus dem Kaiserlichen Gesundheitsamte 1910; 34: 293–304.
  25. Austrian R. Pneumococcus: the first one hundred years. Rev. Infect. Dis. 1981; 3(2): 183–9.
  26. Gordon M.H. Identification of the Meningococcus. J. Hyg. (Lond). 1918; 17(2–3): 290–315.
  27. Gordon M.H. Identification of the meningococcus. J. R. Army Med. Corps 1915; 25: 411–23.
  28. Jochmann G. Versuche zur Serodiagnostik und Serotherapie der epidemischen Genickstarre. Dtsch. Med. Wochenschr. 1906; 32: 788–93.
  29. Flexner S. Concerning a serum therapy for experimental infection with Diploccoccus intracellularis. J. Exp. Med. 1907; (9): 168–85.
  30. Flexner S. The results of the serum treatment in 1300 cases of epidemic meningitis. J. Exp. Med. 1913; 17: 553–76.
  31. Rolleston H. The Lumleian Lectures on cerebro-spinal fever: Delivered before the Royal College of Physicians of London. Br. Med. J. 1919; 1(3045): 573–5.
  32. Rolleston H. The Lumleian Lectures on cerebro-spinal fever: Delivered before the Royal College of Physicians of London. Br. Med. J. 1919; 1(3040): 406–8.
  33. Waterhouse R. A case of suprarenal apoplexy. Lancet 1911; 177(4566): 577–8.
  34. Friderichsen C. Waterhouse-Friderichsen syndrome. Acta Endocrinol. (Copenh.). 1955; 18(4): 482–92.
  35. Glover J.A. The Cerebro-spinal Fever Epidemic of 1917 at X Depot. J. Hyg. (Lond.). 1918; 17(2–3): 350–65.
  36. Glover J.A. Observations on the Meningococcus Carrier-Rate in relation to density of population in Sleeping Quarters. J. Hyg. (Lond). 1918; 17(4): 367–79.
  37. Glover J.A. «Spacing out» in the prevention of military epidemics of cerebro-spinal fever. Br. Med. J. 1918; 2(3019): 509–12.
  38. Rake G., Scherp H.W. Studies on meningococcus infection: III. The antigenic complex of the meningococcus – a type-specific substance. J. Exp. Med. 1933; 58(3): 341–60.
  39. Schwentker F.F., Gelman S., Long P.H. Landmark article April 24, 1937. The treatment of meningococcic meningitis with sulfanilamide. Preliminary report. By Francis F. Schwentker, Sidney Gelman, and Perrin H. Long. JAMA 1984; 251(6): 788–90.
  40. Beeson P.B., Westerman E. Cerebrospinal fever: analysis of 3,575 case reports, with special reference to sulphonamide therapy. Br. Med. J. 1943; (1): 497–500.
  41. Rosenberg D.H., Arling P.A. Landmark article Aug 12, 1944: Penicillin in the treatment of meningitis. By D.H. Rosenberg and P.A.Arling. JAMA 1984; 251(14): 1870–6.
  42. Zhu P., van der Ende A., Falush D., Brieske N., Morelli G., Linz B. et al. Fit genotypes and escape variants of subgroup III Neisseria meningitidis during three pandemics of epidemic meningitis. Proc. Natl. Acad. Sci. USA 2001; 98(9): 5234–9.
  43. Chen M., Rodrigues C.M.C., Harrison O.B., Zhang C., Tan T., Chen J. et al. Author Correction: Invasive meningococcal disease in Shanghai, China from 1950 to 2016: implications for serogroup B vaccine implementation. Sci. Rep. 2018; 8(1): 13484.
  44. de Souza A.L., Seguro A.C. Two centuries of meningococcal infection: from Vieusseux to the cellular and molecular basis of disease. J. Med. Microbiol. 2008; 57(Pt 11): 1313–21.
  45. Platonov A.E., Kharit S.M., Platonova O.V. [Vaccine prevention of meningococcal infection in the world and in Russia]. Epidemiologiya i vaktsinoprofilaktika 2009; 5(48): 32–46. (In Russ.).
  46. Rodrigues C.M.C., Maiden M.C.J. A world without bacterial meningitis: how genomic epidemiology can inform vaccination strategy. F1000Res. 2018; (7): 401.
  47. Pokrovskiy V.I., Favorova L.A., Kostyukova N.N. [Meningococcal infection]. Moscow: Meditsina, 1976. (In Russ.).


About the Autors

Prof. Alexander E. Platonov, BD, Head, Laboratory of Epidemiology of of Zoonoses, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; е-mail: platonov@pcr.ru; ORCID: https://orcid.org/0000-0001-7450-0081
Olga V. Platonova, Researcher, Laboratory of Zoonoses, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; е-mail: oplatonova@pcr.ru
Prof. Victor V. Maleev, MD, Аcademician of the Russian Academy of Sciences, Advisor to the Director for Sciencе, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; e-mail: maleyev@pcr. ru; ORCID: http://orcid.org/0000-0001-5748-178X


Similar Articles

Back to Content

Бионика Медиа